Prostate carcinoma
Item
biopsy-proven prostate cancer
boolean
C0600139 (UMLS CUI [1])
Risk factors Quantity Intermediate Risk Prostate carcinoma
Item
one or two risk factors for intermediate prostate cancer:
boolean
C0035648 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3640764 (UMLS CUI [1,3])
C0600139 (UMLS CUI [1,4])
Gleason score
Item
gleason score 7
boolean
C3203027 (UMLS CUI [1])
TNM clinical staging
Item
t2b-t2c
boolean
C3258246 (UMLS CUI [1])
Prostate specific antigen measurement
Item
psa 10-20 microg/l
boolean
C0201544 (UMLS CUI [1])
Requirement Absent Antiandrogen therapy
Item
no need for androgen deprivation therapy
boolean
C1514873 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0279492 (UMLS CUI [1,3])
Eligibility MRI
Item
eligible fo mri
boolean
C1548635 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
Therapeutic radiology procedure Radical
Item
radical radiotherapy
boolean
C1522449 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma
Item
locally advanced or metastatic prostate cancer
boolean
C0600139 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C0936223 (UMLS CUI [2])
Radiotherapy to pelvis
Item
previous rt to pelvic reason
boolean
C1536155 (UMLS CUI [1])
Disease Severe
Item
other severe disease
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Malignant Neoplasm Previous
Item
previous cancer within 5 years
boolean
C0006826 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Urinary symptoms Severe International Prostate Symptom Score
Item
severe urinary symptoms at the start of the study (i-pss over 20)
boolean
C0426359 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1998280 (UMLS CUI [1,3])
Cavity Wide Post TURP
Item
wide cavity after turp
boolean
C1510420 (UMLS CUI [1,1])
C0332464 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
C0040771 (UMLS CUI [1,4])